Αποτελέσματα Αναζήτησης
12 Αυγ 2020 · Cancer and its treatment can have profound effects on bone health. Clinicians treating cancer patients need to be aware of the multidisciplinary treatments available to reduce skeletal morbidity from metastatic disease and minimise cancer treatment-induced damage to the normal skeleton.
- ABC 5
For the purpose of advanced breast cancer (ABC) guidelines,...
- Fertility Preservation and Post-Treatment Pregnancies in Post-Pubertal Cancer Patients
These guidelines provide a framework for fertility...
- ABC 5
Treating cancer with hormones is called hormone therapy, hormonal therapy, or endocrine therapy. Hormone therapy is mostly used to treat certain kinds of breast cancer and prostate cancer that depend on sex hormones to grow. A few other cancers can be treated with hormone therapy, too.
18 Σεπ 2019 · Estrogens and androgens maintain bone mass and mitigate bone loss. 8 Cancer treatments, such as gonadotropin-releasing hormone (GnRH) agonists and chemotherapy-induced ovarian failure (CIOF) in premenopausal women, aromatase inhibitors (AIs) in postmenopausal women, and antiandrogens in men with NMPC, cause cancer-treatment induced bone loss. 9 ...
Hormone therapy is used for two main reasons. Treat cancer. Hormone therapy can stop or slow cancer's growth and reduce the chance it will return. Ease cancer symptoms. Hormone therapy may be used to reduce or prevent symptoms in men with prostate cancer who are not able to have surgery or radiation therapy.
The most common symptom of bone cancer is pain in the bones and joints, which may be worse at night or during activity. Other symptoms may include: swelling over the affected part of the bone
Treatment is usually to control the cancer and your symptoms. Treatments include hormone therapy, radiotherapy, bisphosphonates and chemotherapy.
20 Μαρ 2018 · In this Review, we describe how adjuvant endocrine therapies of breast and prostate cancer impair bone health and outline evidence from randomised controlled trials of strategies to reduce risk of fracture.
